| 000 | 01567 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515034335.0 | ||
| 264 | 0 | _c20060808 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0300-8916 | ||
| 024 | 7 |
_a10.1177/030089160609200303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUlutin, H Cuneyt | |
| 245 | 0 | 0 |
_aThe value of postoperative radiotherapy in renal cell carcinoma: a single-institution experience. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_a202-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xpathology |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xpathology |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aRadiotherapy, Conformal |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAksu, Gorkem | |
| 700 | 1 | _aFayda, Merdan | |
| 700 | 1 | _aKuzhan, Okhan | |
| 700 | 1 | _aTahmaz, Lutfu | |
| 700 | 1 | _aBeyzadeoglu, Murat | |
| 773 | 0 |
_tTumori _gvol. 92 _gno. 3 _gp. 202-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089160609200303 _zAvailable from publisher's website |
| 999 |
_c16458528 _d16458528 |
||